Review Article
Role and Progression of Radiotherapy for Locally Advanced Esophageal Cancer
Takeo Takahashi*, Keiichiro Nishimura and Takafumi Yamano
Department of Radiation Oncology, Saitama Medical Center, Saitama Medical University, Japan
- Corresponding Author:
- Takeo Takahashi, MD, PhD
Department of Radiation Oncology
Saitama Medical Center
Saitama Medical University
1981, Kamoda, Kawagoe
Saitama 350-8550, Japan
Tel: +81-49-228-3441
Fax: +81-49-228-3753
E-mail: taketaka@saitama-med.ac.jp
Received Date: May 20, 2013; Accepted Date: July 03, 2013; Published Date: July 05, 2013
Citation: Takahashi T, Nishimura K, YAmano T (2013) Role and Progression of Radiotherapy for Locally Advanced Esophageal Cancer. J Gastroint Dig Syst S1:005. doi: 10.4172/2161-069X.S1-005
Copyright: © 2013 Takahashi T, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Abstract
Radiotherapy plays an important role in the treatment of locally advanced esophageal cancer. And, definitive chemoradiotherapy is widely accepted treatment methods for advanced esophageal cancer. Radiation dose-escalation has failed to improve local control or survivals. However, irradiation techniques have been advancing markedly. 3-dimensional radiotherapy, intensity modulated radiotherapy (IMRT), and particle beam therapy is a highly precise radiotherapy in which the dose distribution can be fitted according to the shape of tumor. Future Directions will evaluate the dose-escalation using highly precise radiotherapy and adequate radiation field for locally advanced radiotherapy.
